Status:
COMPLETED
Effect of Rifampin on Bosutinib When Both Are Given to Healthy People
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Study to examine whether rifampin has an effect on the pharmacokinetics of bosutinib.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy men age 18-50
- Healthy women of nonchildbearing potential, age 18-50
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00725426
Start Date
July 1 2008
End Date
August 1 2008
Last Update
April 27 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.